‘Non-inferiority’-studies: mogelijkheden en kanttekeningen

Methodologie van onderzoek 3
Stand van zaken
07-05-2012
Darius Soonawala en Olaf M. Dekkers

‘Non-inferiority’ trials. Tips for the critical readerResearch methodology 3

Conflict of interest: none declared. Financial support: none declared.

  • The aim of non-inferiority trials is to show that a new treatment is not less effective than standard treatment, in other words ‘non-inferior’.

  • The non-inferiority margin should be determined before a study commences. This margin determines the maximal magnitude of difference in effectiveness permissible if it is to be concluded that a new treatment is not less effective than the standard treatment.

  • There is usually a good reason for a non-inferiority design. For example, because the new treatment is easier to use, provides better cost-effectiveness or has fewer side effects.

  • The reader of a non-inferiority trial should consider a number of aspects critically: (a) the reason for use of this study design, (b) the assumed benefit of the new treatment, (c) the rationale for the choice of non-inferiority margin and (d) the choice of the standard therapy with which the new treatment is compared.